Testing the Addition of the Anti-cancer Viral Therapy Telomelysin⢠to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
NRG Oncology
NRG Oncology
National Institutes of Health Clinical Center (CC)
Rigshospitalet, Denmark
Inhibrx Biosciences, Inc
Providence Health & Services
M.D. Anderson Cancer Center